Davol Inc., Subsidiary of C.R. Bard

FDA Regulatory Profile

Davol Inc., Subsidiary of C.R. Bard appears in FDA public data with 0 recalls, 1 510(k) clearance, 0 FDA inspections, and 0 compliance actions on record. Its most recent 510(k) clearance was granted on July 16, 2019.

Summary

Total Recalls
0
510(k) Clearances
1
Inspections
0
Compliance Actions
0

Recent 510(k) Clearances

K-NumberDeviceDate
K191287OptiFix AT Absorbable Fixation System with Articulating Technology – 30 Fasteners, OptiFix AT AbsorbJuly 16, 2019